{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T21:45:43Z","timestamp":1782423943654,"version":"3.54.5"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006571","name":"Canterbury District Health Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006571","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.ijantimicag.2020.105972","type":"journal-article","created":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T20:15:00Z","timestamp":1586808900000},"page":"105972","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Determinants of vancomycin nephrotoxicity when administered to outpatients as a continuous 24-hour infusion"],"prefix":"10.1016","volume":"55","author":[{"given":"Stephen T.","family":"Chambers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1320-1499","authenticated-orcid":false,"given":"Sharon J.","family":"Gardiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul K.L.","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon C.","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip G.","family":"Drennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C.L.","family":"Metcalf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2020.105972_bib0001","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/jac\/dkt402","article-title":"Risk factors for nephrotoxicity in patients receiving outpatient continuous infusions of vancomycin in an Australian tertiary hospital","volume":"69","author":"Norton","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105972_bib0002","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/jac\/dkn080","article-title":"Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy","volume":"62","author":"Ingram","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105972_bib0003","series-title":"Therapeutic Guidelines: Antibiotics. Version 16","year":"2019"},{"key":"10.1016\/j.ijantimicag.2020.105972_bib0004","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2146\/ajhp080434","article-title":"Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists","volume":"66","author":"Rybak","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ijantimicag.2020.105972_bib0005","author":"Rybak","year":"2020","journal-title":"Am J Health-Syst Pharm"},{"key":"10.1016\/j.ijantimicag.2020.105972_bib0006","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ijantimicag.2018.12.014","article-title":"The dosing and monitoring of vancomycin: what is the best way forward?","volume":"53","author":"Drennan","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2020.105972_bib0007","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/cid\/ciz051","article-title":"Vancomycin area under the curve and acute kidney injury: a meta-analysis","volume":"69","author":"Aljefri","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105972_bib0008","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/AAP.0000000000000130","article-title":"Accuracy and consistency of modern elastomeric pumps","volume":"39","author":"Weisman","year":"2014","journal-title":"Reg Anesth Pain Med"},{"key":"10.1016\/j.ijantimicag.2020.105972_bib0009","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1128\/AAC.01602-07","article-title":"Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity","volume":"52","author":"Lodise","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105972_bib0010","unstructured":"Vancomycin dosing guidelines (adults). Antimicrobial Guidelines, Canterbury District Health Board, Christchurch, New Zealand. Available at:https:\/\/www.pinkbook.org.nz\/index.htm?toc.htm?90640.htm(navigate to page 90761 \u201cVancomycin Dosing Guidelines (Adults)\u201d)."},{"key":"10.1016\/j.ijantimicag.2020.105972_bib0011","first-page":"604","article-title":"CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)","volume":"150","author":"Levey","year":"2009","journal-title":"A new equation to estimate glomerular filtration rate. Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2020.105972_bib0012","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"Quan","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ijantimicag.2020.105972_bib0013","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/phar.2191","article-title":"Review and validation of Bayesian dose-optimizing software and equations for calculation of the vancomycin area under the curve in critically ill patients","volume":"38","author":"Turner","year":"2018","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2020.105972_bib0014","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02478-16","article-title":"Pilot study of a Bayesian approach to estimate vancomycin exposure in obese patients with limited pharmacokinetic sampling","volume":"61","author":"Carreno","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105972_bib0015","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/cpt.726","article-title":"The nephrotoxicity of vancomycin","volume":"102","author":"Filippone","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2020.105972_bib0016","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1681\/ASN.2016080867","article-title":"Vancomycin-associated cast nephropathy","volume":"28","author":"Luque","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ijantimicag.2020.105972_bib0017","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijantimicag.2010.10.013","article-title":"Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy","volume":"37","author":"Wong-Beringer","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2020.105972_bib0018","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5694\/mja16.00628","article-title":"Reducing medication errors in hospital discharge summaries: a randomised controlled trial","volume":"206","author":"Tong","year":"2017","journal-title":"Med J Aust"},{"key":"10.1016\/j.ijantimicag.2020.105972_bib0019","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijmedinf.2009.09.002","article-title":"Accuracy of medication documentation in hospital discharge summaries: a retrospective analysis of medication transcription errors in manual and electronic discharge summaries","volume":"79","author":"Callen","year":"2010","journal-title":"Int J Med Inform"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920301291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920301291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:35:48Z","timestamp":1760376948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857920301291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0924857920301291"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105972","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determinants of vancomycin nephrotoxicity when administered to outpatients as a continuous 24-hour infusion","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105972","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105972"}}